Impaired sperm function after spinal cord injury in the rat is associated with altered cyclic adenosine monophosphate signaling.
Our previous observations of changes in the expression of cAMP-dependent genes and the cAMP-responsive element modulator (CREM) in rat testicular cells after spinal cord injury (SCI) implied abnormal cAMP signaling as one of the mechanisms underlying the effects of SCI on spermatogenesis. It was postulated that such effects might contribute to abnormal sperm function after SCI. In this study, we examined this possibility. In spinal cord-contused (SCC) and -transected (SCX) rats, impaired sperm motility was accompanied by an increase in sperm cAMP content. Treatment of SCX rats with exogenous testosterone or follicle-stimulating hormone resulted in a further decrease in sperm motility, whereas sperm cAMP either increased or remained unchanged. These effects differed from those in sham control rats that received identical treatments. Results of these experiments also demonstrated that impaired sperm motility in SCC and SCX rats was accompanied by decreases in sperm viability and mitochondrial potential, thus suggesting a possible link between these changes. We concluded that impaired sperm motility after SCI was associated with decreases in sperm viability and mitochondrial potential. These effects occurred in the face of elevated sperm cAMP content and changes in its regulation, suggesting that altered cAMP signaling events might contribute to impairment of sperm motility and perhaps other sperm functions after SCI.
Wang
Shulun
S
Department of Surgery, Division of Urology, University of Medicine and Dentistry, New Jersey Medical School, Newark, NJ 07103, USA.
Wang
Guichun
G
Barton
Beverly E
BE
Murphy
Thomas F
TF
Huang
Hosea F S
HF
D000818:Animals; D001562:Benzimidazoles / Q000378:metabolism; D002232:Carbocyanines / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D000242:Cyclic AMP / Q000502:physiology*; D005456:Fluorescent Dyes / Q000378:metabolism; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D008297:Male; D009930:Organic Chemicals / Q000378:metabolism; D010750:Phosphoproteins / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000502:physiology*; D013081:Sperm Motility / Q000502:physiology*; D013091:Spermatogenesis / Q000502:physiology; D013094:Spermatozoa / Q000187:drug effects / Q000378:metabolism; D013119:Spinal Cord Injuries / Q000503:physiopathology*; D013739:Testosterone / Q000494:pharmacology
D001562:Benzimidazoles; D002232:Carbocyanines; D005456:Fluorescent Dyes; D009930:Organic Chemicals; D010750:Phosphoproteins; C093207:SYBR-14; C068624:5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine; D013739:Testosterone; D005640:Follicle Stimulating Hormone; D000242:Cyclic AMP